NCT01518985View on ClinicalTrials.gov

The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Bendavia

Bendavia for infusion Intravenous infusion (0.25mg/kg/hr) for 4 hours

DRUG

Sterile saline (0.9%)

Sterile saline for infusion (0.9%) Intravenous infusion for 4 hours

OTHER

Cigarette smoking

One unfiltered cigarette will be smoked at approximately 30 minutes post-study-drug administration start.

Trial Locations (1)

33014-3616

Clinical Pharmaology of Miami, Miami

All Listed Sponsors
lead

Stealth BioTherapeutics Inc.

INDUSTRY

NCT01518985 - The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking | Biotech Hunter | Biotech Hunter